Anterix CLO sells 4,357 shares after option exercise

Anterix’s chief legal officer exercised options and sold shares, with part of the exercise settled through share withholding rather than cash.

This filing corrects an earlier one, and you can read the original Form 4 if you want to see what changed.

Rhea-AI Filing Summary

Anterix Inc. (ATEX) reported that Chief Legal Officer & Corp Sec Gena L. Ashe exercised stock options for 6,833 shares of common stock at $34.96 per share on September 8, 2026. The exercise was handled on a cashless basis, with 2,769 shares withheld to cover the exercise price and income tax obligations, and the remaining shares largely sold in open-market transactions.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 5 txns

Insider Ashe Gena L

Role Chief Legal Officer & Corp Sec

Sold 4,357 shs ($372K)

Approx. gross sale proceeds $372K

Approx. exercise cost $239K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F2	6,833	$0.00	$0.00
Sale	Common Stock	293	$85.44	$25K
Exercise	Common Stock	6,833	$34.96	$239K
Exercise Price or Tax Liability	Common Stock F1	2,769	$86.27	$239K
Sale	Common Stock	4,064	$85.44	$347K

Holdings After Transaction: Stock Option (Right to Buy) — 35,658 contracts (Direct); Common Stock — 9,238 shares (Direct)

Footnotes (2)

1. F1. The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.
2. F2. The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.

Key Figures

Options exercised: 6,833 shares Exercise price: $34.96 per share Shares withheld for exercise and taxes: 2,769 shares +4 more

7 metrics

Options exercised 6,833 shares Stock option exercise by Gena L. Ashe on September 8, 2026

Exercise price $34.96 per share Price for the 6,833 shares of common stock acquired via option exercise

Shares withheld for exercise and taxes 2,769 shares Withheld on a cashless basis to cover exercise price and tax obligations

Shares sold (larger sale) 4,064 shares Open-market or private sale on September 8, 2026 at $85.44 per share

Shares sold (additional sale) 293 shares Separate sale on September 8, 2026 at $85.44 per share

Sale price $85.44 per share Price for both reported sales of Anterix common stock

Net shares sold 4,357 shares Combined total of reported common stock sales on September 8, 2026

Key Terms

cashless basis, income tax withholding and remittance obligations, stock option, withholding of shares

4 terms

cashless basis financial

"paid the exercise price on a cashless basis, resulting in the Issuer withholding"

An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.

income tax withholding and remittance obligations financial

"to pay the exercise price and to satisfy its income tax withholding and remittance obligations"

stock option financial

"The Reporting Person exercised a stock option to purchase 6,833 shares"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

withholding of shares financial

"The withholding of shares referenced here does not involve an open market sale"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Anterix (ATEX) disclose about Gena L. Ashe’s stock option exercise?

Anterix disclosed that Gena L. Ashe exercised stock options for 6,833 shares of common stock at $34.96 per share on September 8, 2026, using a cashless basis in which shares were withheld instead of paying the exercise price in cash.

How many Anterix (ATEX) shares were withheld to cover the option exercise and taxes?

In connection with the option exercise, Anterix reported that 2,769 shares of common stock were withheld to pay the exercise price and satisfy income tax withholding and remittance obligations. The filing notes that this withholding did not involve any open-market sale of stock.

How many Anterix (ATEX) shares did Gena L. Ashe sell on September 8, 2026?

The filing reports open-market or private sales of 4,064 shares and a separate sale of 293 shares of Anterix common stock on September 8, 2026, both at a price of $85.44 per share, following the option exercise.

Was a Rule 10b5-1 trading plan used for Gena L. Ashe’s Anterix (ATEX) transactions?

No. The filing indicates no Rule 10b5-1 trading plan was affirmed for these transactions, and there is no footnote stating that the sales or the option exercise were made pursuant to any pre-arranged trading plan.

What additional share disposition was reported for Anterix (ATEX) in connection with the option exercise?

Beyond market sales, the Form 4/A shows 2,769 shares of Anterix common stock were disposed of under code F, meaning they were withheld to pay the exercise price or tax liability tied to the stock option exercise, rather than sold into the market.

What does the footnote say about the Anterix (ATEX) option exercise mechanics?

The footnote explains that the option to purchase 6,833 shares at $34.96 per share was exercised on a cashless basis, and that Anterix withheld 2,769 shares to cover the exercise price and its income tax withholding and remittance obligations, without any open-market sale for that portion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 04:09 PM Accepted by SEC EDGAR 09/11/2026 - 04:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ashe Gena L

(Last) (First) (Middle)

3 GARRET MOUNTAIN PLAZA

SUITE 401

(Street)

WOODLAND PARK NEW JERSEY 07424

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer & Corp Sec

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/08/2026

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2026		S		293	D	$85.44	9,238	D
Common Stock	09/08/2026		M		6,833	A	$34.96	16,071	D
Common Stock	09/08/2026		F		2,769(1)	D	$86.27	13,302	D
Common Stock	09/08/2026		S		4,064	D	$85.44	9,238	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$34.96	09/08/2026		M			6,833	(2)	05/20/2035	Common Stock	6,833	$0	35,658	D

Explanation of Responses:

1. The Reporting Person exercised a stock option to purchase 6,833 shares of the Issuer's Common Stock for $34.96 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding an aggregate of 2,769 shares of the Issuer's Common Stock subject to the stock option to pay the exercise price and to satisfy its income tax withholding and remittance obligations in connection with the exercise of the stock option. The withholding of shares referenced here does not involve an open market sale of stock.

2. The option shares subject to this option shall vest and become exercisable in three equal annual installments, with 1/3 of the option shares vesting and becoming exercisable on May 20, 2026, and with the remaining option shares vesting and becoming exercisable in 2 equal annual installments thereafter.

Remarks:

	/s/ Gena L. Ashe	09/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)